Introduction
============

Yeast replicative lifespan (RLS) has been studied extensively to understand genetic determinants of lifespan and the mechanisms of aging. Aging is a complicated multifactorial process and a number of major determinants have been described. These include genome stability, metabolism, stress resistance, and chromatin-dependent gene regulation, in addition to random (stochastic) events (Jazwinski, [@B15], [@B16]). We have previously demonstrated one mechanism of lifespan determination that results from mitochondrial dysfunction. This mechanism, termed the retrograde response, is a form of inter-organelle signaling that impacts nuclear gene expression, compensates for the loss of tricarboxylic acid cycle intermediates, and increases RLS (Kirchman et al., [@B20]; Liu and Butow, [@B28]). Deletion of mitochondrial DNA activates this mechanism (Kirchman et al., [@B20]), but it also appears to function during normal yeast aging during which the extent of activation of the retrograde response is commensurate with accumulating mitochondrial dysfunction (Borghouts et al., [@B4]).

The retrograde response is a programmed pathway. The Rtg2 protein responds to a signal generated by dysfunctional mitochondria. Rtg2 then binds to Mks1 which releases its inhibition of the Rtg1--Rtg3 transcription factor, allowing its translocation to the nucleus (Sekito et al., [@B35]; Dilova et al., [@B9], [@B8]). The Rtg1--Rtg3 transcription factor binds to the sequence GTCAC in the target genes' promoters resulting in increased expression of these genes (Liao and Butow, [@B27]; Rothermel et al., [@B34]). However, the initial event signaling mitochondrial dysfunction is not known.

On the surface, there seem to be three possible mitochondrial signals that could signal the retrograde response. The first is a drop in the concentration of ATP due to a loss of respiratory function. The second could be an increase in reactive oxygen species (ROS) generated by dysfunctional mitochondria. The third mechanism is a loss of mitochondrial membrane potential (MMP). Loss of MMP is an attractive possibility because aging yeast cells exhibit reduced MMP and activate the retrograde response (Lai et al., [@B25]; Borghouts et al., [@B4]). Furthermore, lowering of MMP with the uncoupler dinitrophenol has been shown to increase RLS in yeast (Barros et al., [@B2]). In this study, we altered MMP in rho^0^ cells by introducing the mutant *ATP1-111* which results in a hyperactive Atp1 subunit of the mitochondrial F~1~-ATPase and an increase in MMP (Francis et al., [@B11]; Veatch et al., [@B40]). In contrast, we induced a decrease in MMP in rho^+^ cells by deletion of *COX4*, which encodes a subunit of cytochrome oxidase. In this way, MMP was altered independent of the presence or absence of mitochondrial DNA. These genetic manipulations facilitate alteration of MMP over the course of a lifespan without the need to replenish chemical agents.

Materials and Methods {#s1}
=====================

Strains and growth conditions
-----------------------------

For lifespan analyses and preparation of RNA, yeast cells were cultured at 30° in YPD (2% peptone, 1% yeast extract, 2% glucose) or YPG (2% peptone, 1% yeast extract, 2% glycerol), as indicated. For some experiments, yeast cells were cultured in SC medium (0.67% yeast nitrogen base without ammonium sulfate and amino acids, 2 g/l complete amino acid drop-out mix, and 2% glucose). For selection of transformants, cells were cultured on SC medium containing all required nutrients except those needed for selection. The strains used in this study were as follows: YPK9 (*MATa*, *ade2-101*^ochre^ *his3-*Δ200 leu2- Δ*1 lys2-801*^amber^ *trp1-* Δ*63 ura3-52* \[*rho*^+^\]), described previously (Kirchman et al., [@B20]) and provided by P.A. Kirchman, Florida Atlantic University, Jupiter, FL; YJR2 (*MATa*, *ade2-101*^ochre^ *his3-* Δ200 leu2- Δ*1 lys2-801*^amber^ *trp1-* Δ63 ura3-52 \[*rho*^0^\]), an ethidium bromide-induced rho^0^ derived from YPK9 as follows. Wild type cells (YPK9) were grown in YPD medium in presence of 25 μg/ml ethidium bromide, overnight at 30°C. Colonies were selected for zero growth on YPG plates and further characterized for loss of mitochondrial DNA by 4′,6-diamidino-2-phenylindole (DAPI) staining. YSK365 *phb1*Δ is a rho^0^ derivative of YPK9 (Kirchman et al., [@B21]).

Plasmids and transformants
--------------------------

All restriction endonucleases were purchased from New England Biolabs Inc., Ipswich, MA, USA. Replacement of the *ATP1* gene with the *ATP1-111* mutation was accomplished by use of a plasmid based on pRS316 containing the mutated gene sequence (Francis et al., [@B11]) and was a kind gift from Peter Thorsness (Department of Molecular Biology, University of Wyoming, Laramie, WY, USA). The *ATP1-111* insert was sequenced to insure that it contained the necessary mutation and that no other functional mutations in the gene sequence were present. The *ATP1-111* insert was excised using *Bam*H1 and *Xba*1 and ligated into pRS306 for integration. The *ATP1* insert was cut once with *Pfm*1, transformed into YJR2 competent cells and selected for growth on plates lacking uracil. *URA3* positive clones were grown overnight in medium lacking uracil and then 5--6 h in YPD. The cultures were then plated on YPD plates containing 5-fluoroorotic acid (FOA, 1 mg/ml, ZYMO Research). The colonies positive for growth on FOA were grown overnight and DNA isolated (Master Pure Yeast DNA Purification Kit, Epicentre Biotechnologies, Madison, WI, USA). The *ATP1-111* sequence was amplified by PCR, cloned into a plasmid vector (Zero Blunt TOPO PCR Cloning kit, Invitrogen, Carlsbad, CA, USA), and sequenced. Transformants containing the correct sequence were analyzed further. Deletion strategies for *RTG2*, *RTG3*, and *COX4* have been previously described (Kirchman et al., [@B20]).

Strains containing the *RTG3*--*GFP* fusion construct were made from *RTG3* deletion strains containing the *URA3* marker. The plasmid pRS416--*RTG3*--*GFP* (TSB2--71; Sekito et al., [@B35]) was a kind gift from Zhengchang Liu (University of New Orleans, New Orleans, LA, USA). The insert containing flanking regions was excised using *Bam*H1 and *Xba*1 and used for transformation. Positive transformants were selected using FOA, as described above, and confirmed by fluorescence microscopy.

RNA isolation and reverse transcription real time polymerase chain reaction (RT-qPCR)
-------------------------------------------------------------------------------------

*CIT2* expression was determined in exponentially growing cells at a density of 5--6 × 10^7^ cells/ml. Cells were grown in YPD and cell densities determined by hemocytometer counts. Cells were centrifuged at 500 × *g*, rinsed once in ice-cold sterile water and snap frozen in liquid nitrogen. RNA was isolated using the hot-acid phenol method (Ausubel et al., [@B1]) and further purified using the RNeasy Mini Kit (Qiagen Inc., Valencia, CA, USA) with on column DNAase digestion. Final concentration of RNA was determined using a nano-drop 2000 spectrophotometer (Thermo Scientific, Wilmington, DE, USA). Reverse transcription of the RNA was performed using Applied Biosystems TaqMan reverse transcription reagents (Life Technologies Corporation, Carlsbad, CA, USA). Quantitative PCR was performed on an ABI 7300 Real Time PCR system using forward primer: 5′CGAAATCTACCCCATCCATG3′ and reverse primer: 5′TCCCATACGCTCCCTGGAATA3′. *CIT2* expression was normalized to expression of *ACT1* amplified using forward primer: 5′TTCCATCCAAGCCGTTTTGT3′ and reverse primer: 5′CAGCGTAAATTGGAACGACGT3′. Relative expression of three additional retrograde target genes was measured. The forward and reverse primers for *IDH1*, *IDH2*, and *ACO1* were respectively: 5′TTGACGTATCGTCCATCATTGTC3′ and 5′GCCTAAGATGGTACCGTACATTGA3′; 5′GCCCTATCTTTGTCAACGGATT3′ and 5′CAACCAGGTTTTTTGTGATAGATTGT3′; 5′CCAAGGTATCAAGTGGGTTGTTATT3′ and 5′CGAAACCGCCCAAGAATCT3′.

Flow cytometry
--------------

Flow cytometry was performed at the Tulane Cancer Center Cell Analysis Core Facility on a BD LSR II multiple laser analyzer. MMP was determined by growing cells overnight to mid-log density (5--6 × 10^7^ cells/ml) in YPD and incubating aliquots with 3′, 3′-dihexyloxacarbocyanine (DiOC~6~(3)) (Invitrogen) for 20 min at 30°. An aliquot was also incubated separately with carbonyl cyanide m-fluoro phenyl hydrazone (FCCP) (Sigma-Aldrich, St. Louis, MO, USA) for 10 min before addition of DiOC~6~(3) to collapse the membrane potential and serve as a control. The cells were centrifuged and washed once with ice-cold Dulbecco's Phosphate Buffered Saline (dPBS; 137.93 mM sodium chloride, 8.06 mM sodium phosphate dibasic, 1.47 mM potassium phosphate monobasic, 2.67 mM potassium chloride, 0.901 mM calcium chloride, and 0.493 mM magnesium chloride) and re-suspended in ice-cold YPD before analysis. Mitochondrial mass was determined by incubating an aliquot of the cells with Mitotracker Green (MTG) (Molecular Probes-Invitrogen, Carlsbad, CA, USA) for 35 min. MTG has been reported to selectively enter and stain mitochondria independent of the MMP (Pendergrass et al., [@B32], and personal observation). The cells were centrifuged, washed once in ice-cold dPBS, and re-suspended in ice-cold YPD for analysis.

Deconvolution microscopy
------------------------

Microscopy of green fluorescent protein (GFP) expressing cells was performed using a Delta Vision deconvolution epi-fluorescence microscope (Applied Precision, Issaquah, WA, USA) equipped with a CoolSnap HQ2 CCD camera and differential interference contrast (DIC) optics. Cells were grown to mid-log phase in SC medium containing 50 ng/ml DAPI and embedded in low temperature gelling agarose prior to imaging. Typically 10--12 optical sections of 0.4 μm thickness were obtained for the fluorescence images. The optical sections were deconvoluted and sum projected to produce the final image.

Replicative lifespan
--------------------

Replicative lifespan analyses were performed (Egilmez and Jazwinski, [@B10]) by spotting 10 μl of logarithmically growing cells from liquid YPD or YPG onto YPD plates (2% agar). Individual un-budded cells were then separated from the population by micromanipulation and allowed to produce buds. These buds (virgin cells) were removed and used as the starting population for RLS analysis. Each determination consisted of 40 virgin cells. For each successive bud removed from these cells, they were counted one generation older. Cells were grown at 30° during the day and at 8.0° overnight for one generation. Growth at low temperature does not affect RLS (Muller et al., [@B31]).

Extrachromosomal ribosomal DNA circle detection
-----------------------------------------------

Yeast strains were grown overnight in 5 ml YPAD (YPD containing 120 μg/ml adenine). DNA was isolated using the spheroplast method (Lai et al., [@B25]). Three micrograms of DNA was digested with *Spe*I. This enzyme does not cut in the rDNA, but releases a 4.1-kb fragment of the *ACT1* gene, which was used for quantification. The DNA was electrophoresed on a 0.7% agarose gel at 1.2 V/cm for 18 h and then transferred to a nylon membrane, which was hybridized with *ACT1* and 35S-rDNA probes. The 35S probe was generated from plasmid pCB12 (Borghouts et al., [@B4]) digested with *Eco*RI. The *ACT1* probe was generated by PCR from genomic DNA of *Saccharomyces* *cerevisiae*. Restriction digested and PCR product were purified by electrophoresis, and labeled with \[α-^32^P\] dCTP, using the RediPrime kit (GE Healthcare, Piscataway, NJ, USA). Blots were scanned using the Typhoon phosphorimager (GE Healthcare, Piscataway, NJ, USA), and quantification was performed using ImageQuant version 5.1 software (Molecular Dynamics, Sunnyvale, CA, USA).

Statistics
----------

Tests of statistical significance were performed using ANOVA or unpaired Student's *t*-test (Statmost 3.0, Data Most Corporation, Sandy, UT, USA). Tukey's *post hoc* analysis was applied where appropriate (SPSS, IBM Corporation, Amonk, NY, USA). Statistical analyses of life spans were performed using the non-parametric Mann--Whitney test. *P*-values ≤ 0.05 (two-sided) were considered statistically significant.

Results
=======

Restoration of MMP in rho^0^ cells and attenuation in rho^+^ cells
------------------------------------------------------------------

We first examined the MMP in rho^0^ and rho^+^ cells. Figure [1](#F1){ref-type="fig"}A shows a DiOC~6~ flow cytometry labeling experiment. DiOC~6~ is taken up by mitochondria in an MMP-dependent manner. Collapse of the MMP by administration of FCCP prevents this uptake and provides a measure of background fluorescence. When corrected for DiOC~6~ uptake in the presence of FCCP and normalized for mitochondrial mass as determined by MTG staining, rho^0^ cells had an average of only 14% of the MMP compared to rho^+^. In rho^0^ cells with the *ATP1-111* mutation (Figure [1](#F1){ref-type="fig"}B), the MMP was partially restored. However, these cells were still unable to grow on glycerol, indicating inability to respire. MMP was also reduced in rho^+^ *cox4*Δ cells compared to rho^+^, but not to the level of the rho^0^ cells (Figure [1](#F1){ref-type="fig"}B). A comparison of the effects of these genetic manipulations on MMP after normalization to mitochondrial mass in this representative experiment is shown in Figure [1](#F1){ref-type="fig"}C.

![**Typical flow cytometry histograms for estimation of MMP**. Cells were grown to mid-log phase and incubated with DiOC~6~(3) alone, DiOC~6~(3) + FCCP, or with MTG, as indicated. The geometric mean fluorescence intensities of 30,000 cells (MI) were used to calculate relative MMP. **(A)** Dye uptake of YPK9 (rho^+^) cells and YJR2 (rho^0^) cells. **(B)** Dye uptake of YJR2 *ATP1-111* cells and YPK9 *cox4*Δ cells. **(C)** MMP normalized to mitochondrial mass (MTG) for cells in **(A,B)**. Values were determined by subtracting the MI of cells treated with DiOC~6~(3) + FCCP from cells treated with DiOC~6~(3) alone and dividing by the intensity of MTG fluorescence.](fgene-02-00102-g001){#F1}

Effect of manipulating the MMP on *CIT2* expression
---------------------------------------------------

We then determined whether increasing MMP in rho^0^ cells interferes with retrograde response signaling by measuring *CIT2* expression. An increase in *CIT2* expression is considered diagnostic for the activation of the retrograde response (Liao and Butow, [@B27]). As shown in Figure [2](#F2){ref-type="fig"}, *CIT2* expression in rho^0^ cells is almost threefold higher than in rho^+^ cells. Increasing the MMP in rho^0^ cells in the presence of the *ATP1-111* mutation significantly reduced *CIT2* expression, suggesting that a decrease in MMP is the initial signal for the retrograde response. *CIT2* expression was significantly higher in the rho^+^ *cox4*Δ strain compared to the rho^+^ control (Figure [2](#F2){ref-type="fig"}), which we would expect since MMP is lower as shown in Figure [1](#F1){ref-type="fig"}. *CIT2* expression was also measured in the rho^0^ *ATP1-111* mutant containing deletions of either *RTG2* or *RTG3*, both of which are transducers of the retrograde response. *CIT2* expression was very low in both cases (Figure [2](#F2){ref-type="fig"}). This was also the case when these genes were deleted in the rho^+^ *cox4*Δ strain (Figure [2](#F2){ref-type="fig"}). These results demonstrate that the activation of *CIT2* depends on retrograde signaling in these strains. The effects of altering MMP on *CIT2* expression were recapitulated by three other retrograde response target genes, *IDH1*, *IDH2*, and *ACO1* (Figure [A1](#FA1){ref-type="fig"} in Appendix).

![***CIT2* expression**. Expression of *CIT2* relative to *ACT1* was determined by qRT-PCR as described in Section ["Materials and Methods."](#s1){ref-type="sec"} The strains used were as follows: YPK9 (rho^+^); YJR2 (rho^0^); YJR2 *ATP1-111*; YPK9 *cox4*Δ; YJR2 *ATP1-111* *rtg2*Δ; YJR2 *ATP1-111* *rtg3*Δ: YPK9 *cox4*Δ *rtg2*Δ; YPK9 *cox4*Δ *rtg3*Δ. Error bars are ± SEM for *N* = 3 or 4 determinations. *P*-values adjusted for multiple comparisons are *P* \< 0.0002 for YPK9 vs. YJR2; *P* \< 0.05 for YJR2 vs. YJR2 *ATP1-111*; *P* \< 0.02 for YPK9 vs. YPK9 *cox4*Δ.](fgene-02-00102-g002){#F2}

Rtg3 translocation to the nucleus is dependent on MMP
-----------------------------------------------------

The translocation of the Rtg1--Rtg3 transcription factor from the cytoplasm to the nucleus is an integral feature of the retrograde response, and it is necessary for the induction of retrograde response target genes such as *CIT2*. We therefore examined the intracellular localization of the Rtg3 protein fused to GFP in the yeast strains in which we manipulated the MMP. This construct has been used previously to monitor Rtg1--Rtg3 translocation, and it is active in supporting induction of *CIT2* expression (Sekito et al., [@B35]). Figure [3](#F3){ref-type="fig"}A shows deconvolution micrographs of cells containing the *RTG3*--*GFP* fusion in place of endogenous *RTG3*. In rho^+^ cells at mid-log growth phase, the Rtg3--GFP protein showed a diffuse, cytoplasmic fluorescence (YPK9). This is in contrast to the rho^0^ cells (YJR2), in which the Rtg3--GFP was seen mainly in the nucleus, as indicated by the colocalization of the GFP fluorescence with the fluorescence of DAPI which binds to the nuclear DNA. When we imaged the rho^0^ *ATP1-111* cells, the Rtg3--GFP localization resembled that in rho^+^ cells, indicating that Rtg3 is not translocated to the nucleus in these cells. In the *cox4*Δ cells, Rtg3 translocation was intermediate to that in the rho^+^ and rho^0^ cells, consistent with the partial activation of the retrograde response indicated by *CIT2* expression (Figure [2](#F2){ref-type="fig"}). These results are quantified in Figure [3](#F3){ref-type="fig"}B. Thus, the localization of Rtg3 is dependent on MMP and consistent with the activation of *CIT2* expression.

![**Fluorescence deconvolution micrographs and corresponding DIC images of cells containing an *RTG3-- GFP* fusion construct**. Cells were harvested at mid-log growth and imaged as described in Section ["Materials and Methods."](#s1){ref-type="sec"} **(A)** Fluorescence and DIC micrographs. YPK9: GFP fluorescence is diffuse with only a few cells showing Rtg3 translocated to the nucleus. YJR2: The majority of the cells show GFP concentrated in the nucleus. YJR2 *ATP1-111*: Translocation pattern resembles that seen for YPK9. YPK9 *cox4*Δ: Cells exhibit a fluorescence pattern intermediate to YPK9 and YJR2. DAPI fluorescence indicates the nucleus. **(B)** Quantification of fluorescence micrograph images. Three separate fields of at least 100 cells each were scored for GFP nuclear translocation. Error bars are ±SEM for *N* = 3 fields.](fgene-02-00102-g003){#F3}

RLS extension depends on MMP
----------------------------

Activation of the retrograde response in rho^0^ cells extends RLS (Kirchman et al., [@B20]). If this activation depends on MMP, we should observe predictable effects on RLS by manipulating the MMP. As shown in Figure [4](#F4){ref-type="fig"}A, RLS in the rho^0^ cells was increased substantially, as previously reported (Kirchman et al., [@B20]). However, the *ATP1-111* mutation completely suppressed the RLS extension. In fact, the RLS was not significantly different than the RLS in rho^+^ cells. This result supports the conclusion that reduced MMP in rho^0^ cells signals the retrograde response resulting in the increase in RLS. Interestingly, the lifespan extension seen in the rho^0^ strain is almost completely abolished even though the MMP is not fully restored, indicating that there must be some threshold reduction in MMP for the retrograde response and RLS extension to be triggered. To provide further support for the role of MMP in the retrograde response, we measured RLS in the rho^+^ *cox4*Δ strain that has a lower MMP than the rho^+^ strain but maintains its mitochondrial DNA. As shown above in Figure [1](#F1){ref-type="fig"}C, deletion of *COX4* in rho^+^ cells resulted in an MMP intermediate to that of the rho^+^ and rho^0^ cells. The RLS was significantly increased in the *COX4* deletion strain also intermediate to that of the rho^+^ and rho^0^ strains (Figure [4](#F4){ref-type="fig"}B). This increase in RLS was due to activation of the retrograde response, as deletion of either *RTG2* or *RTG3* abrogated the RLS extension (Figure [4](#F4){ref-type="fig"}B). Thus, the activation of the retrograde response and extension of RLS is dependent on MMP.

![**Replicative lifespan determinations**. **(A)** YPK9, YJR2, and YJR2 *ATP1-111*. Mean life spans: YPK9: 21.2 generations; YJR2: 26.3 generations; YJR2 *ATP1-111*: 22.0 generations. *P* = 0.009 YPK9 vs. YJR2. *P* = 0.71 YPK9 vs. YJR2 *ATP1-111*. **(B)** YPK9, YJR2, YPK9 *cox4*Δ, YPK9 *cox4*Δ *rtg2*Δ, and YPK9 *cox4*Δ *rtg3*Δ. Mean life spans: YPK9: 19.8, YJR2: 29.8, YPK9 *cox4*Δ: 24.1, YPK9 *cox4*Δ *rtg2*Δ: 19.1, and YPK9 *cox4*Δ *rtg3*Δ: 18.4. *P* = 1 × 10^−6^ YPK9 vs. YJR2; *P* = 0.007 YPK9 vs. YPK9 *cox4*Δ; *P* = 0.61 YPK9 vs. YPK9 *cox4*Δ *rtg2*Δ; *P* = 0.39 YPK9 vs. YPK9 *cox4*Δ *rtg3*Δ; *P* = 0.0045 YJR2 vs. YPK9 *cox4*Δ.](fgene-02-00102-g004){#F4}

ERC accumulation in rho^0^ cells is dependent on MMP and the mitochondrial nucleoid
-----------------------------------------------------------------------------------

Extrachromosomal ribosomal DNA circle (ERC) levels are higher in rho^0^ as compared to rho^+^ cells, and they accumulate with replicative age (Conrad-Webb and Butow, [@B7]; Sinclair and Guarente, [@B37]; Borghouts et al., [@B4]). We previously showed that ERC production in rho^0^ cells involves Rtg2 which cannot suppress their accumulation when it is engaged in retrograde signaling (Borghouts et al., [@B4]). We therefore expected that increasing MMP in rho^0^ cells would reduce Rtg2 participation in retrograde signaling and suppress formation of ERC. ERC accumulation was significantly increased in the rho^0^ as compared to the rho^+^ strain (Figure [5](#F5){ref-type="fig"}). Elevation of MMP in the *ATP1-111* rho^0^ strain reduced ERC accumulation to a level approaching that found in the rho^+^ cells. Interestingly, ERC levels in the *cox4*Δ rho^+^ strain were the same or lower than in the rho^+^ cells. This suggests that defects in, or the absence of the mitochondrial nucleoid itself in addition to MMP decrease are necessary to trigger ERC formation.

![**Effect of MMP on the production of ERC**. Genomic DNA was isolated from YPK9, YPK9 *cox4*Δ, YJR2, and YJR2 *ATP1-111* strains grown in YPDA. Genomic DNA digested with *Spe*I was hybridized on a Southern blot with a 35S-rDNA (top) and *ACT1* (bottom) probes for ERC quantification. Bands representing ERC (thin arrows) and the hybridization signal of the genomic rDNA copies (thick arrow) are indicated. For quantification of ERC, signal intensities of all ERC bands were normalized against hybridization signals of *ACT1* and combined for each strain. Numbers indicate intensity of ERC bands in the different strains relative to those in YPK9. The blot shown is representative of three separate determinations.](fgene-02-00102-g005){#F5}

A free radical scavenger does not affect activation of the retrograde response
------------------------------------------------------------------------------

Mitochondrial membrane potential changes are associated with ROS production by mitochondria (Gourlay et al., [@B13]). Interruption of the electron transport chain at any point results in increased ROS in yeast, the levels of which depend on the exact nature of the disruption (Barros et al., [@B3]). Thus, ROS could be downstream of MMP in retrograde response signaling. We used the free radical scavenger and antioxidant phenyl *tert* butyl nitrone (PBN) and measured ROS by fluorescence microscopy, using the peroxide-sensitive dye 2′,7′-dichlorodihydrofluorescein diacetate (H~2~DCFDA). ROS were nearly undetectable in the four strains used in this study. We previously reported that YSK365 *phb1*Δ cells produce ample ROS under normal growth conditions (Kirchman et al., [@B21]). PBN substantially quenched ROS production at 0.1 mg/ml in YSK365 *phb1*Δ cells (Figure [6](#F6){ref-type="fig"}A), confirming its ROS-scavenging effect. As shown in Figure [6](#F6){ref-type="fig"}B, increasing concentrations of PBN had no effect on *CIT2* expression, indicating that ROS do not appear to play a role in retrograde response activation. Quenching ROS also did not block RLS extension in rho^0^ cells, indicating that the activation of the retrograde response and concomitant extension of RLS by decreased MMP is not mediated by ROS (Figure [6](#F6){ref-type="fig"}C).

![**Effect of PBN on ROS, *CIT2* expression, and RLS**. **(A)** PBN at 0.1 mg/ml significantly reduces oxidation of H~2~DCFDA. Percent fluorescence intensity is expressed as mean fluorescence intensity per cell area, determined by the SoftWorx analysis software provided with the deconvolution epi-fluorescence microscope. Error bars are ±SD. *P* = 0.009 for YSK365 *phb1*Δ cells grown in the presence or absence of PBN. **(B)** Effect of increasing concentrations of PBN on *CIT2* expression in YPK9 and YJR2 cells. Error bars are ±SEM for three or four experiments. The effect of PBN concentration on *CIT2* expression was not significant for either YPK9 or YJR2 by ANOVA. **(C)** RLS of YPK9 and YJR2 in the presence of 0.1 mg/ml PBN. Mean life spans are YPK9: 18.3, YPK9 + 0.1 mg/ml PBN: 17.9, YJR2: 25.1; YJR2 + 0.1 mg/ml PBN: 26.0. *P* = 0.0001 YPK9 vs. YJR2; *P* = 0.4 for YPK9 ± 0.1 mg/ml PBN; *P* = 0.7 for YJR2 ± 0.1 mg/ml PBN.](fgene-02-00102-g006){#F6}

Discussion
==========

We have shown that a decrease in MMP is the event proximal to the mitochondrion that signals the retrograde response. Elevation of MMP in rho^0^ cells possessing the *ATP1-111* mutation (Figure [1](#F1){ref-type="fig"}) suppressed translocation of the Rtg3 transcription factor from the cytoplasm to the nucleus (Figure [3](#F3){ref-type="fig"}) and induction of *CIT2* expression (Figure [2](#F2){ref-type="fig"}), a diagnostic of the retrograde response. Furthermore, it suppressed the extension of RLS seen in rho^0^ cells possessing wild type *ATP1* (Figure [4](#F4){ref-type="fig"}). In contrast, reduction of MMP in rho^+^ cells possessing the *COX4* deletion induced the translocation of Rtg3 to the nucleus (Figure [3](#F3){ref-type="fig"}) and expression of *CIT2* (Figure [2](#F2){ref-type="fig"}), while increasing the RLS (Figure [4](#F4){ref-type="fig"}). There is an inverse relationship between MMP and retrograde response activation, as measured by *CIT2* induction. However, *CIT2* expression levels, unlike translocation of Rtg3, are not directly proportional to RLS extension. This suggests that in addition to the MMP there are other signals generated by mitochondria that impinge on the retrograde response and affect RLS. It should also be noted that expression of *CIT2* itself does not determine RLS (Kirchman et al., [@B20]).

One candidate for the additional signal impacting the retrograde response is the Ras2 pathway. *RAS2* is known to be necessary for activation of the retrograde response in terms of both *CIT2* expression and RLS extension (Kirchman et al., [@B20]). This Ras2 signaling is likely to be cAMP-independent (Sun et al., [@B39]). Ira1 and Ira2 are components of the mitochondrial proteome in yeast (Sickmann et al., [@B36]). These GTPase-activating proteins negatively regulate Ras2, and it is known that deletion of *IRA2* either alone or with *IRA1* causes constitutively high Ras2--GTP loading (Colombo et al., [@B6]). It has also been shown that glucose phosphorylation enhances Ras2--GTP loading, likely through inhibition of the Ira proteins (Colombo et al., [@B6]). Whether differences in signaling through Ras2 due to loss of all or most of the mitochondrial DNA are necessary for full activation of the retrograde response awaits further studies.

The nutritional status-responsive TOR pathway modulates the retrograde response (Komeili et al., [@B22]; Liu et al., [@B30]), and it has been shown that *TOR1* is involved in RLS extension by nutrient limitation in yeast (Kaeberlein et al., [@B19]). As shown recently, the downstream target genes of the retrograde response and nutrient limitation, whether through reduction of glucose or non-essential amino acids, are very similar (Wang et al., [@B41]), even though the signaling pathways differ (Jiang et al., [@B18]). The common denominator here may be the TOR pathway (Jazwinski, [@B17]). Interestingly, *TOR1* has been implicated in another signaling pathway from the mitochondrion to the nucleus, called mitochondrial back-signaling that extends RLS (Heeren et al., [@B14]). Recently, it has been found that defects in the mitochondrial translation control machinery also extend RLS by reduction of TOR signaling concomitant with disruption of respiration (Caballero et al., [@B5]). Besides the involvement of TOR, all of these pathways share in common mitochondrial defects that result in respiratory dysfunction.

Our analysis of ERC accumulation is also informative with regard to the complexity of the retrograde response. There was an increase in ERC accumulation in rho^0^ cells (Figure [5](#F5){ref-type="fig"}), as expected, and this was significantly reduced by the *ATP1-111* mutation. This indicates a reduction in retrograde signaling through Rtg2, which suppresses rDNA instability when it is available to do so (Borghouts et al., [@B4]). However, the rho^+^ *cox4*Δ cells, which still contain mitochondrial DNA, have ERC levels similar to rho^+^ cells. This indicates some direct effect of the mitochondrial DNA/nucleoid on retrograde response signaling and ERC production. Certain *atp2* mutants which retain mitochondrial DNA also do not accumulate ERC, even though they are deficient in MMP (Lai et al., [@B25]). Perhaps these differences in ERC accumulation reflect the operation of inter-genomic signaling, a cellular response to loss of mitochondrial DNA (Poyton and McEwen, [@B33]). This inter-genomic signaling response seems to bypass Rtg2 and directly affects Rtg3 in an altered mechanism of RLS extension in rho^0^ cells (Woo and Poyton, [@B42]). We propose a heuristic model to encompass the effects of loss of mitochondrial DNA together with decrease in MMP on the retrograde response and RLS (Figure [7](#F7){ref-type="fig"}). This model takes into account the mutually exclusive roles of Rtg2 in retrograde signaling and maintenance of genome stability. It also explains why the effects of attenuated MMP on the retrograde response and RLS extension are different in cells that possess (rho^+^) and those that lack (rho^0^) mitochondrial DNA.

![**Heuristic model describing the differential effects on RLS of respiratory dysfunction and mitochondrial DNA loss**. Mitochondrial dysfunction induced by respiratory chain defects lowers MMP engaging the Rtg2 protein in retrograde signaling, leading to extension of RLS. The MMP deficit is not sufficient to saturate the Rtg2 pool, leaving free protein to suppress ERC production. The mitochondrial dysfunction induced by the loss of mitochondrial DNA is so severe that it results in a very low MMP and the attendant activation of the retrograde response and RLS extension, such that no free Rtg2 remains to suppress ERC production. The activation of the retrograde response in this case is further intensified by an effect of mitochondrial DNA loss that bypasses Rtg2.](fgene-02-00102-g007){#F7}

Although we have shown here that the MMP is a signal proximal to the mitochondrion that activates the retrograde response, how this signal interacts with the next signal transducer in this pathway, Rtg2, is not clear. Increases in ROS have been proposed as a signal resulting from mitochondrial dysfunction. ROS production increases in yeast with replicative age and may be the cause of apoptotic death at the end of their lifespan (Laun et al., [@B26]). However, the retrograde signaling examined here does not seem to be due to an increase in ROS. The ROS scavenger PBN did not suppress the induction of *CIT2* expression or increase in RLS in rho^0^ cells (Figure [6](#F6){ref-type="fig"}).

Another possible candidate for the initiator of mitochondria-to-nucleus signaling is a decrease in ATP concentration brought on by a dysfunctional respiratory chain. In this scenario, Rtg2 functions as an ATP sensor, which is consistent with the requirement of its ATP-binding domain for its function (Liu and Butow, [@B29]). In the presence of ATP, Rtg2 would be released from Mks1 which would inhibit retrograde signaling. However direct support for this mechanism has not been shown because local ATP concentrations in organelles cannot reliably be measured. It also seems unlikely that rho^0^ cells would have a reduced ATP concentration compared to wild type cells because, in general, ATP concentrations have been shown to be tightly regulated (Goldberg et al., [@B12]) and rho^0^ cells provided with adequate glucose increase glycolysis to compensate for the lack of ATP production from respiration. In addition, ATP must fuel the hyperactive F~1~-ATPase in the *ATP1-111* mutant in rho^0^ cells to raise MMP and suppress the retrograde response, which would lower rather than increase ATP levels. This is inconsistent with the notion that low ATP signals the retrograde response. Furthermore, addition of glucose to aerobically growing yeast cells in a chemostat results in a rapid drop in cellular ATP followed by a recovery to a new steady state (Somsen et al., [@B38]), indicating that ATP is maintained at relatively constant levels.

The mechanism by which the decline in MMP is coupled to signaling through Rtg2 remains to be resolved. Recently, a tethering complex in yeast between mitochondria and the endoplasmic reticulum which appears necessary for phospholipid exchange and which would facilitate communication between the two compartments has been demonstrated (Kornmann et al., [@B23]). This communication could involve direct protein linkage between the two compartments or through a gradient of a small molecule such as calcium which could signal mitochondrial dysfunction (Kornmann and Walter, [@B24]). The retrograde response interacts with the other mechanisms of inter-organelle signaling, as well as caloric restriction pathways as part of a robust and highly regulated program of mitochondria-to-nucleus signaling. How the MMP interacts with these other pathways awaits further study.
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![**Expression of retrograde response target genes**. Expression of *IDH1, IDH2*, and *ACO1* relative to *ACT1* was determined by qRT-PCR as described in Section ["Materials and Methods."](#s1){ref-type="sec"} The strains used were as follows: YPK9 (rho^+^), YJR2 (rho^0^), YJR2 *ATP1-111*, and YPK9 *cox4*Δ. Error bars are SEM for *N* = 6 determinations. Expression of *IDH1*, *IDH2*, and *ACO1* increased in YJR2 compared to YPK9 (*P* = 3.96 × 10^−4^, 3.06 × 10^−4^, and 0.0024, respectively) and in YPK9 *cox4*Δ compared to YPK9 (*P* = 0.0102, 0.0081, and 0.0051, respectively). Expression of *IDH1*, *IDH2*, and *ACO1* decreased in YJR2 *ATP1-111* compared to YJR2 (*P* = 1.08 × 10^−4^, 2.73 × 10^−4^, and 0.0021, respectively). *P*-values are adjusted for multiple comparisons.](fgene-02-00102-a001){#FA1}
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